# TScan Therapeutics, Inc. (TCRX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TCRX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 2.03M | $ -59.03M | $ -52.38M | $ 90.89M | $ 69.02M |
| 2025 | $ 10.57M | $ -132.87M | $ -143.07M | $ 94.14M | $ 123.12M |
| 2024 | $ 2.96M | $ -134.01M | $ -120.50M | $ 97.38M | $ 240.97M |
| 2023 | $ 22.76M | $ -96.47M | $ -69.75M | $ 92.43M | $ 150.87M |
| 2022 | $ 15.12M | $ -73.98M | $ -79.01M | $ 85.98M | $ 99.43M |
| 2021 | $ 12.05M | $ -57.80M | $ -69.68M | $ 6.04M | $ 160.78M |
| 2020 | $ 1.38M | $ -33.28M | $ -9.25M | $ 7.43M | $ -42.46M |
| 2019 | N/A | N/A | N/A | $ 4.89M | $ 42.54M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 1.32 |
| Liabilities / Eq | 1.48 |
| Current Ratio | 3.37 |

## Other views

- [Metrics](https://sponda.capital/en/TCRX.md)
- [Charts](https://sponda.capital/en/TCRX/charts.md)
- [Compare](https://sponda.capital/en/TCRX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.